Capricor Therapeutics (CAPR) Assets Average (2011 - 2026)
Capricor Therapeutics (CAPR) posted quarterly Assets Average of $341.1 million for Q1 2026, up 110.41% year-over-year from $162.1 million in Q1 2025, and up 41.43% quarter-over-quarter from $241.2 million in Q4 2025.
Capricor Therapeutics (CAPR) Assets Average (2011 - 2026) Analysis & Trends
Capricor Therapeutics' Assets Average history runs 16 years deep, the most recent figure standing at $341.1 million for Q1 2026.
- In Q1 2026, Assets Average rose 110.41% year-over-year to $341.1 million; the TTM figure through Mar 2026 stood at $341.1 million (up 110.41% YoY), while the FY2025 annual figure was $263.2 million, up 129.67% from the prior year.
- Assets Average for Q1 2026 stood at $341.1 million, up from $241.2 million in the prior quarter.
- The five-year high for Assets Average was $341.1 million in Q1 2026, with the low at $41.6 million in Q3 2023.
- The 5-year median for Assets Average is $56.0 million (2022), against an average of $101.6 million.
- The sharpest annual moves came in 2023 and 2025: Assets Average dropped 25.74% in 2023, then soared 227.55% in 2025.
- Capricor Therapeutics' Assets Average stood at $52.0 million in 2022, then retreated by 7.82% to $47.9 million in 2023, then jumped by 174.73% to $131.7 million in 2024, then jumped by 83.12% to $241.2 million in 2025, then jumped by 41.43% to $341.1 million in 2026.
- Business Quant data shows CAPR's Assets Average at $341.1 million in Q1 2026, $241.2 million in Q4 2025, and $130.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 3.29 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.86 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 16.08 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.82 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.34 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 2.09 Bn |
| 10 | Capricor Therapeutics | 383.47 Mn | 383.47 Mn | - | 341.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 341.12 Mn |
| Dec 31, 2025 | 241.19 Mn |
| Sep 30, 2025 | 130.00 Mn |
| Jun 30, 2025 | 143.67 Mn |
| Mar 31, 2025 | 162.12 Mn |
| Dec 31, 2024 | 131.72 Mn |
| Sep 30, 2024 | 65.61 Mn |
| Jun 30, 2024 | 43.86 Mn |
| Mar 31, 2024 | 54.09 Mn |
| Dec 31, 2023 | 47.94 Mn |
| Sep 30, 2023 | 41.58 Mn |
| Jun 30, 2023 | 49.94 Mn |
| Mar 31, 2023 | 51.98 Mn |
| Dec 31, 2022 | 52.01 Mn |
| Sep 30, 2022 | 56.00 Mn |
| Jun 30, 2022 | 61.49 Mn |
| Mar 31, 2022 | 53.13 Mn |
| Dec 31, 2021 | 42.22 Mn |
| Sep 30, 2021 | 41.52 Mn |
| Jun 30, 2021 | 41.74 Mn |